Canker Sore Clinical Trial
Official title:
Salivary Catecholamines in Aphthous Stomatitis
Verified date | April 2015 |
Source | University of California, Davis |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The purpose of this study is to examine how compounds produced in patients with canker sores affect wound healing.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2009 |
Est. primary completion date | December 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age 18 or older, both genders - History of recurrent aphthous ulcers with 4 or more episodes per year Exclusion Criteria: - History of salivary gland disease including Sjogren's disease, parotitis, and sialolithiasis - History of benign or malignant salivary gland tumor - History of celiac disease, ulcerative colitis or Crohn's disease - Patients on medications that affect salivary flow such as anti-depressants and anti-cholinergic medications |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of California, Davis |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04914533 -
Luminance RED for Canker Sores
|
N/A |